Sarcoidosis clinical trials
The registry lists 271 studies for Sarcoidosis across more than 10 countries. 51 are recruiting or about to start. 162 of them are mainly about Sarcoidosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05. Counting its narrower condition Sarcoidosis, Pulmonary too: 305 studies, 63 open.
Get an email when these change. Save the Sarcoidosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Assistance Publique - Hôpitaux de Paris (15) · University of Cincinnati (14) · Post Graduate Institute of Medical Education and Research, Chandigarh (11) · Maastricht University Medical Center (8) · National Heart, Lung, and Blood Institute (NHLBI) (6) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (5) · Yale University (4) · University of Aarhus (4)
What is being tested here
Drugs under test in Sarcoidosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Hydroxychloroquine | 1 | 2 | 3 |
| Methotrexate | 1 | 1 | 2 |
| Prednisolone | 1 | 0 | 2 |
| LAM-001 | 1 | 0 | 1 |
| Gabapentin | 1 | 0 | 1 |
| Benzonatate | 1 | 0 | 1 |
| Fluorine F 18 FAPI-74 | 1 | 0 | 1 |
| Baricitinib | 1 | 0 | 1 |
| Sirolimus | 1 | 0 | 1 |
| PF-06700841 | 1 | 1 | 1 |
Drug classes tested here JAK inhibitors 2 open · Tyrosine kinase inhibitors (TKIs) 2 open · Corticosteroids 1 open · Endothelin receptor antagonists 3 · Stimulants 3
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Dec 2026Cardiac Sarcoidosis Randomized Trial · Phase 3 · Ottawa Heart Institute Research Corporation
- Jan 2027Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis · Phase 3 · Assistance Publique - Hôpitaux de Paris
- Nov 2026Diagnostic Value of EBUS-Guided Transbronchial Mediastinal Cryobiopsy Versus Conventional Bronchoscopic Approaches for Stage I/II Sarcoidosis · China-Japan Friendship Hospital
- Dec 2026Prednisolone for 12 Versus 6 Months to Treat Pulmonary Sarcoidosis · Post Graduate Institute of Medical Education and Research, Chandigarh
- Dec 2026Vitamin D Homeostasis in Sarcoidosis · University of Texas Southwestern Medical Center
- Dec 2026Repurposing Tilmanocept for Cardiac Sarcoidosis · Duke University
- Dec 2026Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens · Johns Hopkins University
- Dec 2026Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression · University of Pennsylvania
- Feb 2027Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis · University Health Network, Toronto
- Mar 2027Cardiac Sarcoidosis Multi-Center Prospective Cohort · Ottawa Heart Institute Research Corporation
Who these studies take
Of the 40 Sarcoidosis studies recruiting now, 30 (75%) set no upper age limit and 1 (3%) stop at 75 or younger. 6 (15%) take children under 18. 0 (0%) are for women only and 1 (3%) for men only; 11 (28%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 6 (15%) | 6 (15%) |
| 18 | 37 (93%) | 37 (93%) |
| 30 | 39 (98%) | 39 (98%) |
| 40 | 39 (98%) | 39 (98%) |
| 50 | 39 (98%) | 40 (100%) |
| 65 | 39 (98%) | 40 (100%) |
| 75 | 39 (98%) | 40 (100%) |
| 85 | 35 (88%) | 36 (90%) |
Across all 271 studies, recruiting or not: 14% stop at 75 or younger and 4% at 65; 15% take children; 0% are for women only and 1% for men only; 15% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Sarcoidosis studies take
Of 59 observational studies under Sarcoidosis, half reached primary completion within 49 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 18 mo10–59 · 32 studies | — | — |
| Observational | 49 mo20–111 · 59 studies | — | 49 mo20–111 · 59 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Newly registered2
- Bronchial Hyperresponsiveness in SarcoidosisNov 5, 2026NCT07919665
- LAM-001 for the Treatment of Sarcoidosis Associated Pulmonary Hypertension (SAPH)Oct 21, 2026NCT07886554
Studies
Recruiting first, then most recently updated. Showing 50 of 271. Browse all 271 → or search them.
- Repurposing Tilmanocept for Cardiac SarcoidosisRecruitingNCT07159074Phase 21 country
- Cardiac Sarcoidosis Multi-Center Prospective CohortRecruitingNCT014773592 countries
- A Study of Brepocitinib in Adults With Cutaneous SarcoidosisRecruitingNCT06978725Phase 2/33 countries
- LAM-001 for the Treatment of Sarcoidosis Associated Pulmonary Hypertension (SAPH)Not yet recruitingNCT07886554Phase 21 country
- Prognostic Value of Clinical Cardiovascular MRIRecruitingNCT017452371 country
- Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary SarcoidosisRecruitingNCT06205121Phase 28 countries
- Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILDNot yet recruitingNCT07859839Phase 41 country
- Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary SarcoidosisRecruitingNCT05841758Phase 41 country
- Vitamin D Homeostasis in SarcoidosisRecruitingNCT03621553Phase 41 country
- Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)RecruitingNCT076042201 country
- Cardiovascular Multimodality Imaging StudyRecruitingNCT066100191 country
- Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic ToolNot yet recruitingNCT077042941 country
- FAPI PET Imaging - An Exploratory StudyNot yet recruitingNCT07705074Phase 1/21 country
- Cardiac Sarcoidosis Randomized TrialRecruitingNCT03593759Phase 35 countries
- Interstitial Lung Disease Research Unit BiobankRecruitingNCT053928811 country
- A Study of the Natural Progression of Interstitial Lung Disease (ILD)RecruitingNCT004703271 country
- EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular DiseasesRecruitingNCT070773041 country
- Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for SarcoidosisRecruitingNCT06220526Not applicable1 country
- Mayo AVC Registry and BiobankRecruitingNCT030492542 countries
- Virtual Patient Groups for Sarcoidosis Associated FatigueRecruitingNCT07073963Not applicable1 country
- Corticosteroid Tapering in SarcoidosisRecruitingNCT07498842Not applicable1 country
- Immunological Mechanisms in SarcoidosisRecruitingNCT065765051 country
- MoMa Signature During GranulomatosisRecruitingNCT059166381 country
- Cardiac Imaging in Systemic Disorders: the ORACLES RegistryNot yet recruitingNCT07134166
- Rheumatology Patient Registry and BiorepositoryRecruitingNCT044020861 country
- A Trial of Baricitinib in Patients With Cardiac SarcoidosisNot yet recruitingNCT06868381Phase 21 country
- Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung DiseaseRecruitingNCT07384897Not applicable1 country
- Cohort of Patients With Systemic Granulomatosis and Associated Biological CollectionRecruitingNCT068548481 country
- Institutional Registry of Rare DiseasesRecruitingNCT065737231 country
- Cell Free DNA in Cardiac SarcoidosisRecruitingNCT03858777Not applicable1 country
- Risk Indicators of Sarcoidosis Evolution-Unified ProtocolRecruitingNCT055671331 country
- Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose SuppressionRecruitingNCT065108941 country
- Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy SpecimensRecruitingNCT051714781 country
- Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)RecruitingNCT062343841 country
- Quantification & Classification of Inflammatory Cells in Uveitis Using OCTRecruitingNCT070657471 country
- Mediastinal EBUS Cryobiopsy Study In SwedenRecruitingNCT063479391 country
- AYLo - AutoimmunitY and Loss of yRecruitingNCT066960271 country
- Evaluation of the Prognostic Value of PET/MRI in Cardiac SarcoidosisRecruitingNCT05954507Not applicable1 country
- Improving Genomic Profiling and Reducing Time to Cancer Treatment Via Targeted Use of Endoscopic UltrasoundEnrolling by invitationNCT06848738Not applicable1 country
- Comparison of the Effects of Yoga and Conventional Physiotherapy Programs in SarcoidosisRecruitingNCT06848608Not applicable1 country
- Prednisolone for 12 Versus 6 Months to Treat Pulmonary SarcoidosisNot yet recruitingNCT06654934Phase 41 country
- Sarcoidosis and Immune Cells in Lung, Lymph Nodes and BloodRecruitingNCT05751447Not applicable1 country
- University of Virginia Natural History StudyEnrolling by invitationNCT048961381 country
- Macrophage PET/CT Imaging Using 64Cu-DOTATATE for the Diagnosis of Cardiac SarcoidosisRecruitingNCT061311121 country
- Expression and Role of the JAK/STAT Pathway in Sarcoidosis Granuloma CellsRecruitingNCT047512791 country
- Fibrosing ILD Biomarkers That Rule AccelerationRecruitingNCT056350321 country
- Diagnostic Criteria in Cardiac SarcoidosisRecruitingNCT047373171 country
- Biomaterial Collection - and Analysis in Cardiac SarcoidosisNot yet recruitingNCT05793398
- Effect of Needle Size in Diagnostic Yield of EBUS-TBNA in Sarcoidosis and LymphomaRecruitingNCT03573362Not applicable1 country
- Sirolimus in Cutaneous SarcoidosisNot yet recruitingNCT05458492Phase 2